1998;82:774 8. S7.4-6. Maron BJ, Spirito P, Shen WK, et al. Implantable cardioverter-defi- brillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA. 2007;298:405 12. S7.4-7. O Mahony C, Jichi F, Pavlou M, et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart J. 2014;35:2010 20. S7.4-8. Spirito P, Autore C, Rapezzi C, et al. Syncope and risk of sudden death in hypertrophic cardiomyopathy. Circulation. 2009;119:1703 10. S7.4-9. O Mahony C, Lambiase PD, Quarta G, et al. The long-term sur- vival and the risks and benefits of implantable cardioverter defi- brillators in patients with hypertrophic cardiomyopathy. Heart. 2012;98:116 25. S7.4-10. Syska P, Przybylski A, Chojnowska L, et al. Implantable cardioverter- defibrillator in patients with hypertrophic cardiomyopathy: effi- cacy and complications of the therapy in long-term follow-up. J Cardiovasc Electrophysiol. 2010;21:883 9. S7.4-11. Adabag AS, Kuskowski MA, Maron BJ. Determinants for clini- cal diagnosis of hypertrophic cardiomyopathy. Am J Cardiol. 2006;98:1507 11. S7.4-12. Afonso LC, Bernal J, Bax JJ, et al. Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technolo- gies. JACC Cardiovasc Imag. 2008;1:787 800. S7.4-13. Girolami F, Ho CY, Semsarian C, et al. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations. J Am Coll Cardiol. 2010;55:1444 53. S7.4-14. Ingles J, Sarina T, Yeates L, et al. Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy. Genet Med. 2013;15:972 7. S7.4-15. Jensen MK, Havndrup O, Christiansen M, et al. Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing. Circulation. 2013;127:48 54. S7.4-16. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two- dimensional echocardiography in 600 patients. 